DMKJ
ABEO icon

David M. Knott Jr’s Abeona Therapeutics ABEO Stock Holding History

David M. Knott Jr’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-198,300
Closed -$993K – 107
2023
Q4 		$993K Buy
198,300
+38,300
+24% +$168K 0.38% 33
2023
Q3 		$674K Hold
160,000
– – 0.26% 47
2023
Q2 		$645K Hold
160,000
– – 0.26% 49
2023
Q1 		$451K Buy
160,000
+10,000
+7% +$26.1K 0.18% 57
2022
Q4 		$462K Buy
+150,000
New +$561K 0.17% 60

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

David M. Knott Jr's ABEO Position: Q1 2024 in Review

David M. Knott Jr sold out of Abeona Therapeutics (ABEO) in Q1 2024, closing a stake of 198,300 shares — an estimated $993K sold.

David M. Knott Jr first reported a position in ABEO in Q4 2022 and held it in 5 quarters. The position peaked at $993K in Q4 2023. 56 funds tracked by Wall St. Rank hold ABEO as of Q1 2024.

  • David M. Knott Jr reported no remaining Abeona Therapeutics position as of Q1 2024 after selling out during the quarter.
  • David M. Knott Jr sold 198,300 Abeona Therapeutics shares in Q1 2024, an estimated $993K.
  • David M. Knott Jr first reported a position in Abeona Therapeutics in Q4 2022 and held it in 5 quarters.
  • David M. Knott Jr's Abeona Therapeutics position peaked at $993K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2024.

Based on David M. Knott Jr's 13F filing for Q1 2024, filed 14 May 2024.